Drug profile · INN
natamycin
NATACYN
natamycin (NATACYN) is a ergosterol sequestering agent. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — natamycin
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 1
- Programs
- 0
- Data quality
- 0.84
Quick answer
natamycin (NATACYN) is a ergosterol sequestering agent. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Ergosterol sequestering agent
Primary target: Ergosterol
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Related patents
Frequently asked questions
What is natamycin?
natamycin (NATACYN) is a ergosterol sequestering agent. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for natamycin?
NATACYN is a marketed brand name for natamycin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of natamycin?
natamycin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.